Valuation Imunon, Inc.

Equities

Delayed Nasdaq Other stock markets 04:00:00 2025-01-17 pm EST			5-day change	1st Jan Change
0.9131 ^USD	+1.68%		+1.47%	-3.88%

Dec. 19	IMUNON, Inc. Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer	CI
Dec. 10	Imunon Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 Ovation 2 Study of Imnn-001	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	38.91	26.6	46.74	10.04	6.392	13.24	13.24	-
Change	-	-31.63%	75.69%	-78.53%	-36.32%	107.16%	0%	-
Enterprise Value (EV)	38.91	26.6	46.74	10.04	6.392	13.24	13.24	13.24
Change	-	-31.63%	75.69%	-78.53%	-36.32%	107.16%	0%	0%
P/E ratio	-2.22x	-1.06x	-2.11x	-0.27x	-0.31x	-0.54x	-0.88x	-1.26x
PBR	-	-	-	-	-	-	-	-
PEG	-	0.1x	0x	-0x	0x	0x	0x	0x
Capitalization / Revenue	77.8x	53.2x	93.5x	20.1x	-	-	-	-
EV / Revenue	0x	0x	0x	0x	-	-	-	-
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-0.64x	-0.48x	-0.36x
EV / FCF	-	-	-	-	-	-3.31x	-0.4x	-0.31x
FCF Yield	-	-	-	-	-	-30.2%	-249%	-320%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-11.55	-10.05	-3.83	-5.03	-2.16	-1.7	-1.035	-0.7267
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.5	0.5	0.5	0.5	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
EBIT ¹	-20.56	-18.49	-21.01	-24.92	-21.03	-20.73	-27.44	-36.48
Net income ¹	-16.85	-21.48	-20.77	-35.9	-19.52	-20.48	-27.42	-36.87
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	25.6500	10.6650	8.1000	1.3500	0.6800	0.9131	0.9131	0.9131
Nbr of stocks (in thousands)	1,517	2,495	5,771	7,434	9,399	14,501	14,501	-
Announcement Date	3/25/20	3/19/21	3/31/22	3/30/23	3/28/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
IMUNON, INC.	-0.54x	-	-	-	13.24M
VERTEX PHARMACEUTICALS INCORPORATED	-263.84x	9.14x	113.74x	-.--%	109B
REGENERON PHARMACEUTICALS, INC.	17.66x	4.47x	11.03x	-.--%	73.33B
ARGENX SE	484.34x	17.19x	-781.7x	-.--%	39.62B
BIONTECH SE	-32.85x	4.96x	-10.25x	-.--%	26.83B
BEIGENE, LTD.	-38.62x	5.55x	-39.22x	-.--%	22.39B
WUXI APPTEC CO., LTD.	16.22x	3.58x	10.24x	+1.86%	20.68B
NEUROCRINE BIOSCIENCES, INC.	35.62x	5.42x	20.34x	-.--%	14.5B
SUMMIT THERAPEUTICS INC.	-62.19x	-	-	-	14.03B
GENMAB A/S	17.99x	3.71x	11.49x	-.--%	13.23B
Average	17.38x	6.75x	-83.04x	+0.23%	33.33B
Weighted average by Cap.	-29.15x	7.71x	-57.31x	+0.12%